ID   87-13
AC   CVCL_RA81
DR   Wikidata; Q54605440
RX   PubMed=1306323;
RX   PubMed=7817386;
RX   PubMed=10328163;
CC   Population: Japanese.
CC   Doubling time: 11.7 days (PubMed=7817386; PubMed=10328163).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   67Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 10-04-25; Version: 6
//
RX   PubMed=10328163; DOI=10.1620/tjem.186.313;
RA   Kobayashi, Shunsuke
RA   Okada, Shinichiro
RA   Hasumi, Toru
RA   Sato, Nobuyuki
RA   Fujimura, Shigefumi
RT   "Modulating activity of indomethacin to vincristine cytotoxicity in
RT   various human carcinoma cells.";
RL   Tohoku J. Exp. Med. 186:313-322(1998).
//
RX   PubMed=7817386; DOI=10.1620/tjem.173.217;
RA   Kobayashi, Shunsuke
RA   Okada, Shinichiro
RA   Yoshida, Hiroyuki
RA   Hasumi, Toru
RA   Sato, Nobuyuki
RA   Inaba, Hirohisa
RA   Nakada, Tasaku
RA   Fujimura, Shigefumi
RT   "Syalil-SSEA1(SLX) levels in supernatant of cultured human lung
RT   carcinoma cell lines.";
RL   Tohoku J. Exp. Med. 173:217-229(1994).
//
RX   PubMed=1306323; DOI=10.1620/tjem.168.375;
RA   Kobayashi, Shunsuke
RA   Fujimura, Shigefumi
RT   "Characterization and the clinical application of cultured human
RT   pulmonary carcinoma cells.";
RL   Tohoku J. Exp. Med. 168:375-386(1992).
//